ABVC BIOPHARMA, INC. (ABVC) Historical Stock Prices
ABVC BIOPHARMA, INC. (ABVC) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ABVC
CIK: 1173313
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Simon & Edward, LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerYen-Ting Chen
Audit LocationRowland Heights, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| DEF 14A | 2026-09-29 | 2026-10-28 | DEFINITIVE PROXY STATEMENT | 0001213900-26-104509 | View SEC Doc Filr Page |
| PRER14A | 2026-09-11 | — | REVISED PRELIMINARY PROXY STATEMENT | 0001213900-26-099293 | View SEC Doc Filr Page |
| 8-K | 2026-08-27 | 2026-08-27 | CURRENT REPORT | 0001213900-26-094152 | View SEC Doc Filr Page |
| PRER14A | 2026-08-25 | — | REVISED PRELIMINARY PROXY STATEMENT | 0001213900-26-093538 | View SEC Doc Filr Page |
| 424B4 | 2026-08-17 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-090779 | View SEC Doc Filr Page |
| 424B4 | 2026-08-17 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-090778 | View SEC Doc Filr Page |
| 424B4 | 2026-08-17 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-090777 | View SEC Doc Filr Page |
| 424B4 | 2026-08-17 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-090775 | View SEC Doc Filr Page |
| PRER14A | 2026-08-12 | — | REVISED PRELIMINARY PROXY STATEMENT | 0001213900-26-088445 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-088348 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-12 | 2026-08-03 | CURRENT REPORT | 0001213900-26-088165 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-03 | CURRENT REPORT | 0001213900-26-084846 | View SEC Doc Filr Page |
| PRE 14A | 2026-07-28 | 2026-07-28 | PRELIMINARY PROXY STATEMENT | 0001213900-26-082298 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-07-02 | CURRENT REPORT | 0001213900-26-074949 | View SEC Doc Filr Page |
| 10-Q | 2026-05-18 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-058104 | View SEC Doc Filr Page |
| NT 10-Q | 2026-05-15 | 2026-03-31 | NOTIFICATION OF LATE FILING | 0001213900-26-057917 | View SEC Doc Filr Page |
| POS AM | 2026-03-27 | — | POST-EFFECTIVE AMENDMENT NO. 5 TO FORM S-1 | 0001213900-26-035543 | View SEC Doc Filr Page |
| 8-K | 2026-03-27 | 2026-03-27 | CURRENT REPORT | 0001213900-26-035499 | View SEC Doc Filr Page |
| DEF 14A | 2026-03-05 | 2026-03-26 | DEFINITIVE PROXY STATEMENT | 0001213900-26-024122 | View SEC Doc Filr Page |
| 10-K | 2026-03-03 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-023063 | View SEC Doc Filr Page |
| 10-Q/A | 2026-03-03 | 2025-09-30 | AMENDMENT NO. 1 TO FORM 10-Q | 0001213900-26-023062 | View SEC Doc Filr Page |
| 8-K | 2026-03-03 | 2026-03-03 | CURRENT REPORT | 0001213900-26-023054 | View SEC Doc Filr Page |
| PRE 14A | 2026-02-05 | 2026-02-05 | PRELIMINARY PROXY STATEMENT | 0001213900-26-012888 | View SEC Doc Filr Page |
| 8-K/A | 2026-01-16 | 2025-04-30 | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-26-005165 | View SEC Doc Filr Page |
| 424B4 | 2025-11-14 | — | PROSPECTUS SUPPLEMENT | 0001213900-25-110903 | View SEC Doc Filr Page |